Touchstone
Last syncNov 1, 2026, 6:55 PM ET

BRKR

Bruker Corp Health Care Laboratory Analytical Instruments Russell 3000
$57.07Close $8.7BMarket cap $32.68 – $64.7552-week range Nov 4, 2026Next report · before the open

Highlights

Cautions

  • Trend not confirmed 7 of 8 conditions · under the 50-day
  • Earnings shrinking EPS −782% year on year
  • Results soon Nov 4, 2026, in 3 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 5, 2026
Off 12-month high 12%
1wk down 0.9% price change
1mo down 11.9% price change
12-month return up 57% market up 11% · its own up 41%
F-score 4 / 9 Weak
Altman Z 2.69 Moderate risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 3.5× price / book
Earnings yield up 0.7% EBIT / enterprise value
Cheaper than 34% of the market · expensive
Revenue growth up 2% year on year
EPS growth down 782% latest quarter · -764 pts
Sales growth up 5% latest quarter · +2 pts
ROE 0% return on equity
Free cash margin up 1% $43.3M FCF
D/E 0.75 long-term debt / equity
Net debt / EBITDA 5.4×
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • profitability slipped from last year
  • issued more shares
  • gross margin narrowed
  • assets working less efficiently
  • generating cash from operations
  • profits backed by cash
  • reduced long-term debt
  • short-term liquidity improved

Repair signals

  • Long-term debt down 10% ($2.1B → $1.9B)

Trade setup

ATR% 5.4% $3.06 a day · 2×ATR $50.95
RS 79 / 99 vs the universe
Trend 7 / 8 under the 50-day
Relative volume 0.9× vs 50-day average
Up/down volume 0.98 50 sessions
Implied move — no option chain · report Nov 4, 2026
Trend template · 7 of 8
  • Price above the 50-day average: fails

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Heavily indebted Net debt is 5.4 times EBITDA — roughly 5 years of earnings before interest, tax and depreciation to repay borrowings in full.
  • Gross margin narrowing Gross margin fell from 49.0% to 45.9%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Aug 4, 2026
Last shock Aug 4, 2026-22% in one session3.7× volumeon results+13% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $3.4B +2% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $2.0B FY2021 · $2.4B FY2022 · $2.5B FY2023 · $3.0B FY2024 · $3.4B FY2025 · $3.4B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$8.3M down to a loss
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $157.8M FY2021 · $280.6M FY2022 · $298.5M FY2023 · $428.5M FY2024 · $113.8M FY2025 · -$8.3M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $43.3M -68% on FY2024
$0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $235.0M FY2021 · $190.4M FY2022 · $145.2M FY2023 · $243.2M FY2024 · $136.0M FY2025 · $43.3M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 46%
  • Net -0%
  • Free cash 1%
0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 47% · Net 8% · Free cash 12% FY2021 · Gross 50% · Net 12% · Free cash 8% FY2022 · Gross 52% · Net 12% · Free cash 6% FY2023 · Gross 51% · Net 14% · Free cash 8% FY2024 · Gross 49% · Net 3% · Free cash 4% FY2025 · Gross 46% · Net -0% · Free cash 1%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $1.6B net debt
  • Cash
  • Long-term debt
$0 $2.5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $681.8M · Long-term debt $842.3M FY2021 · Cash $1.1B · Long-term debt $1.2B FY2022 · Cash $645.5M · Long-term debt $1.2B FY2023 · Cash $488.3M · Long-term debt $1.2B FY2024 · Cash $183.4M · Long-term debt $2.1B FY2025 · Cash $298.8M · Long-term debt $1.9B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 152.14m +0.1% since FY2020
152.14m 145.16m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 151.99m FY2021 · 150.75m FY2022 · 147.02m FY2023 · 145.16m FY2024 · 151.68m FY2025 · 152.14m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $2.0B $2.4B $2.5B $3.0B $3.4B $3.4B
Gross margin 47% 50% 52% 51% 49% 46%
Operating income $248.3M $413.3M $432.7M $436.9M $253.1M $68.2M
Net income $157.8M $280.6M $298.5M $428.5M $113.8M -$8.3M
Net margin 8% 12% 12% 14% 3% -0%
Earnings per share $1,020,698.58 $1,835,186.40 $1,997,991.97 $2.91 $0.76 -$0.05
Free cash flow $235.0M $190.4M $145.2M $243.2M $136.0M $43.3M
Free cash margin 12% 8% 6% 8% 4% 1%
Cash $681.8M $1.1B $645.5M $488.3M $183.4M $298.8M
Long-term debt $842.3M $1.2B $1.2B $1.2B $2.1B $1.9B
Shareholders' equity $961.2M $1.1B $1.1B $1.4B $1.8B $2.5B
Shares outstanding 151.99m 150.75m 147.02m 145.16m 151.68m 152.14m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 5, 2026 Quarterly ↗ Jun 30, 2026 36d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 27, 2026 Annual ↗ Dec 31, 2025 58d
Nov 5, 2025 Quarterly ↗ Sep 30, 2025 36d
Aug 6, 2025 Quarterly ↗ Jun 30, 2025 37d
May 7, 2025 Quarterly ↗ Mar 31, 2025 37d
Mar 3, 2025 Annual ↗ Dec 31, 2024 62d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Aug 9, 2024 Quarterly ↗ Jun 30, 2024 40d
May 10, 2024 Quarterly ↗ Mar 31, 2024 40d
Feb 29, 2024 Annual ↗ Dec 31, 2023 60d
Nov 9, 2023 Quarterly ↗ Sep 30, 2023 40d

Current reports

FiledDisclosed
Oct 29, 2026 Other events ↗
Aug 14, 2026 Other events ↗
Aug 4, 2026 Results ↗
Jul 30, 2026 Other events ↗
May 21, 2026 Shareholder vote ↗
May 15, 2026 Other events ↗
May 6, 2026 Results ↗
Apr 28, 2026 Other events ↗
Apr 10, 2026 Director or officer change ↗
Apr 1, 2026 Director or officer change ↗
Feb 20, 2026 Director or officer change · Other events ↗
Feb 12, 2026 Results ↗